Published on 2 Apr 2024 on GuruFocus.com via Yahoo Finance
Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders, has reported an insider sell according to a recent SEC filing. The company's Chief Operating Officer, Mark Jacobson, sold 24,662 shares of the company on April 1, 2024. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Warning! GuruFocus has detected 3 Warning Signs with AXSM.